Methyl 3-chlorosulfonylthiophene-2-carboxylate

We are Methyl 3-chlorosulfonylthiophene-2-carboxylate CAS:59337-92-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: Methyl 3-chlorosulfonylthiophene-2-carboxylate
CAS.NO:59337-92-7
Synonyms:
2-methoxycarbonyl-3-thiophenesulfonyl chloride
2-Carbomethoxy-3-thiophenesulfonyl chloride
Methyl-3-chlorosulfonylthiophene-2-carboxylate
Methylchlorosulfonylthiophenecarboxylate
3-(chlorosulfonyl)thiophene-2-carboxylic acid methyl ester;
2-(methoxycarbonyl)thiophene-3-sulphonyl chloride
2-(METHOXYCARBONYL)THIOPHENE-3-SULFONYL CHLORIDE
Methyl 3-(Chlorosulfonyl)-2-thiophenecarboxylate
2-(carbomethoxy)thiophene-3-sulfonyl chloride
 
Molecular Formula:C6H5ClO4S2
Molecular Weight:240.68400
 
Physical and Chemical Properties:
Density: 1.568 g / cm3
Boiling point: 364.8ºC at 760 mmHg
Melting point: 61-64 ° C (lit.)
Flash point: 174.4ºC
Refractive index: 1.56
 
Specification:
Appearance:white crystalline powder
Purity:≥99%
Moisture Content: ≤0.2%
Impurity: ≤0.3%
 
Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Duloxetine CAS:116539-60-7
Intermediates of Duloxetine hydrochloride CAS:136434-34-9
Intermediates of Sitaxsentan sodium CAS:210421-74-2
 

Methyl 3-chlorosulfonylthiophene-2-carboxylate


Related News: The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.2-Amino-3-nitro-4-picoline CAS:6635-86-5 This part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs.160968-99-0 The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said.2,3-dihidrobenzo [b] furan-5-carbaldehído CAS:55745-70-5 Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.

Related Products
Product Name
4-Amino-3-iodobenzotrifluoride View Details
2,2,3,5,6,6-hexamethylheptan-4-one View Details
N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide View Details
pyrrolidone hydrotribromide manufacturer 4,7,13,16,21-pentaoxa-1,10-diazabicyclo[8.8.5]tricosane Cas:31364-42-8 manufacturer CAS:778-25-6 Silanol, methyldiphenyl manufacturer 3-Mercaptopropylmethyldimethoxysilane manufacturer 1H,1H,2H,2H-Perfluorooctylmethyldichlorosilane Cas:73609-36-6 manufacturer